关注
Janet B McGill
Janet B McGill
Washington University School of Medicine
在 dom.wustl.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ...
New England Journal of Medicine 361 (21), 2019-2032, 2009
24432009
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22412006
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16362012
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial
GL Bakris, V Fonseca, RE Katholi, JB McGill, FH Messerli, RA Phillips, ...
Jama 292 (18), 2227-2236, 2004
12062004
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine Practice 23 (2), 207-238, 2017
11482017
Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial
RW Beck, T Riddlesworth, K Ruedy, A Ahmann, R Bergenstal, S Haller, ...
Jama 317 (4), 371-378, 2017
11422017
AACE comprehensive diabetes management algorithm 2013
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine practice: official journal of the American College of …, 2013
1140*2013
Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study
PA Hollander, SC Elbein, IB Hirsch, D Kelley, J McGill, T Taylor, SR Weiss, ...
Diabetes care 21 (8), 1288-1294, 1998
9671998
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study
WF Keane, BM Brenner, D De Zeeuw, JP Grunfeld, J McGill, WE Mitch, ...
Kidney international 63 (4), 1499-1507, 2003
7542003
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, Y Handelsman, G Grunberger, D Einhorn, MJ Abrahamson, ...
Endocrine Practice 26 (1), 107-139, 2020
6402020
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial
PJ Lustman, LS Griffith, RE Clouse, KE Freedland, SA Eisen, EH Rubin, ...
Psychosomatic medicine 59 (3), 241-250, 1997
6311997
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine Practice 22 (1), 84-113, 2016
6262016
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants
KM Miller, RW Beck, RM Bergenstal, RS Goland, MJ Haller, JB McGill, ...
Diabetes care 36 (7), 2009-2014, 2013
5872013
American Association of Clinical Endocrinologists and American College of Endocrinology–clinical practice guidelines for developing a diabetes mellitus comprehensive care plan …
Y Handelsman, ZT Bloomgarden, G Grunberger, G Umpierrez, ...
Endocrine Practice 21 (4), 413-437, 2015
5852015
Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial
RW Beck, TD Riddlesworth, K Ruedy, A Ahmann, S Haller, D Kruger, ...
Annals of internal medicine 167 (6), 365-374, 2017
5282017
Anxiety and poor glycemic control: a meta-analytic review of the literature
RJ Anderson, AB Grigsby, KE Freedland, M De Groot, JB McGill, ...
The International Journal of Psychiatry in Medicine 32 (3), 235-247, 2002
4662002
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
JB McGill, DJ Schneider, CL Arfken, CL Lucore, BE Sobel
Diabetes 43 (1), 104-109, 1994
4181994
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American …
LM Laffel, JB McGill, DJ Gans
The American journal of medicine 99 (5), 497-504, 1995
3911995
The effect of ruboxistaurin on nephropathy in type 2 diabetes
KR Tuttle, GL Bakris, RD Toto, JB McGill, K Hu, PW Anderson
Diabetes care 28 (11), 2686-2690, 2005
3672005
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study
P Raskin, BW Bode, JB Marks, IB Hirsch, RL Weinstein, JB McGill, ...
Diabetes care 26 (9), 2598-2603, 2003
3592003
系统目前无法执行此操作,请稍后再试。
文章 1–20